<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00938782</url>
  </required_header>
  <id_info>
    <org_study_id>SU-11062007-818</org_study_id>
    <nct_id>NCT00938782</nct_id>
  </id_info>
  <brief_title>Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade</brief_title>
  <official_title>A Prospective, Randomized, Double-Blinded Study of the Effect on Improved Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospira, now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asses the effect of the use of Patient State Index (PSI) monitoring on difference in&#xD;
      emergence profiles in the elderly (age &gt;65 yrs) population to develop a cost-benefit profile.&#xD;
&#xD;
      Assess differences in Quality of Life using the QoR-40 (a validated 40-item questionnaire on&#xD;
      quality of recovery from anesthesia) between the two treatment groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Extubation</measure>
    <time_frame>Measured from time of end anesthesia to time of tracheal extubation.</time_frame>
    <description>The exact time from end of last anesthetic drug to time of tracheal extubation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Anesthesia, General</condition>
  <arm_group>
    <arm_group_label>Active Monitoring with SEDLine Monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient group randomized to active monitoring with SEDLine monitor for titration of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blinded monitoring with SeEDLine Monitor</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient group randomized to blinded monitoring with SEDLine monitor for titration of anesthesia. Data captured but not used for titration of anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sedline</intervention_name>
    <arm_group_label>Active Monitoring with SEDLine Monitor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is male or female.&#xD;
&#xD;
          -  Patient is 65 years of age or older.&#xD;
&#xD;
          -  Patient has a physical status between ASA I and III. (Appendix C).&#xD;
&#xD;
          -  Patient scheduled for general anesthesia for non-cardiac surgery expected to last at&#xD;
             least one hour.&#xD;
&#xD;
          -  Patient able to communicate in English.&#xD;
&#xD;
          -  Patient has signed an approved informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's age is less than 65 years&#xD;
&#xD;
          -  Anesthetic duration of less than one hour expected&#xD;
&#xD;
          -  Treatment of beta blockers contra-indicated&#xD;
&#xD;
          -  Not a candidate for general anesthesia&#xD;
&#xD;
          -  Patient requires regional anesthesia with general anesthesia.&#xD;
&#xD;
          -  ASA physical status of IV or V. (Appendix C)&#xD;
&#xD;
          -  Patient has known drug or alcohol abuse.&#xD;
&#xD;
          -  Patient has scalp or skull abnormalities such as psoriasis, eczema, angioma, scar&#xD;
             tissue, burr holes, cranial implants (such as plates, shunts, etc.).&#xD;
&#xD;
          -  Patient has experienced a head injury with loss of consciousness within the last year.&#xD;
&#xD;
          -  Patient has known neurological and psychiatric disorder that interferes with the&#xD;
             patient's level of consciousness.&#xD;
&#xD;
          -  Known concurrent chronic usage of psychoactive or anticonvulsive drugs within the last&#xD;
             90 days, or any use in the last 7 days (i.e. tricyclic antidepressants, MAO&#xD;
             inhibitors, lithium, SSRIs, neuroleptics, anxiolytics or antipsychotics).&#xD;
&#xD;
          -  Patient has any medical condition which, in the judgment of the investigator, renders&#xD;
             them inappropriate for participation in this study, such as Guillen Bare syndrome&#xD;
&#xD;
          -  Known hypersensitivity to the intended anesthetic agents including significant&#xD;
             post-operative nausea or vomiting.&#xD;
&#xD;
          -  Uncontrolled hypertension (unresponsive to medication): Systolic BP &gt; 180 mmHg or&#xD;
             Diastolic BP &gt; 105 mmHg&#xD;
&#xD;
          -  Pre-Op baseline heart rate &lt; 45 beats per minute&#xD;
&#xD;
          -  Weight 50% greater than ideal body weight&#xD;
&#xD;
          -  Already monitored for EP or EEG, i.e., Spinal cord cases&#xD;
&#xD;
          -  Actual anesthetic duration &lt; 1 hour (assessed after emergence).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David R. Drover</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>July 10, 2009</study_first_submitted>
  <study_first_submitted_qc>July 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2009</study_first_posted>
  <results_first_submitted>January 23, 2015</results_first_submitted>
  <results_first_submitted_qc>February 9, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 19, 2015</results_first_posted>
  <last_update_submitted>February 9, 2015</last_update_submitted>
  <last_update_submitted_qc>February 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>David R. Drover</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>1 - SEDLine™ Group</title>
          <description>Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on vital plus Sedline monitor.</description>
        </group>
        <group group_id="P2">
          <title>2- Control Group</title>
          <description>Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on physiologic vitals without input from Sedline monitor.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32">Pre-induction of anesthesia</participants>
                <participants group_id="P2" count="35">Monitoring started pre-induction of anesthesia</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32">Upon discharge from PACU</participants>
                <participants group_id="P2" count="35">Upon discharge from PACU</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups.</population>
      <group_list>
        <group group_id="B1">
          <title>1 - SEDLine™ Group</title>
          <description>Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on vital plus Sedline monitor.&#xD;
Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups: a group whose titration of sevoflurane was based on SEDLine™ data (SEDLine™ group).</description>
        </group>
        <group group_id="B2">
          <title>2 - CONTROL Group</title>
          <description>Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on physiologic vitals without input from Sedline monitor.&#xD;
Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups: a group whose titration of sevoflurane was not based on SEDLine™ data (CONTROL group)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="35"/>
            <count group_id="B3" value="67"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75" spread="5.7"/>
                    <measurement group_id="B2" value="74.5" spread="6.7"/>
                    <measurement group_id="B3" value="74.8" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Extubation</title>
        <description>The exact time from end of last anesthetic drug to time of tracheal extubation.</description>
        <time_frame>Measured from time of end anesthesia to time of tracheal extubation.</time_frame>
        <population>All patients enrolled in both groups.</population>
        <group_list>
          <group group_id="O1">
            <title>1 - Sedline Group</title>
            <description>Patient group randomized to active monitoring with Sedline monitor.</description>
          </group>
          <group group_id="O2">
            <title>2 - Control Group</title>
            <description>Patient groups randomized to active monitoring versus blinded monitoring. This group had teh clinician blinded to output of the Sedline monitor.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Extubation</title>
          <description>The exact time from end of last anesthetic drug to time of tracheal extubation.</description>
          <population>All patients enrolled in both groups.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0" spread="5.9"/>
                    <measurement group_id="O2" value="12.5" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day during anesthesia period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>1 - SEDLine Group</title>
          <description>Patient groups randomized to active monitoring. This group had Sedline monitor used to titrate anesthesia.</description>
        </group>
        <group group_id="E2">
          <title>Group 2 - Control Group</title>
          <description>Patient groups randomized to monitoring with blinded data not used to titrate anesthesia.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David R Drover</name_or_title>
      <organization>Stanford University</organization>
      <phone>650-725-0364</phone>
      <email>ddrover@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

